CLMT vs MS · rev $4.19B vs P/E 20, $344.27B cap
Calumet Specialty Products Partners (CLMT) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Calumet Specialty Products Partners (CLMT) is a specialty chemicals company listed on NASDAQ.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported CLMT revenue for 2024-12-31 was $4.19B. Net income was -$222.0M. Revenue was up 0.2% from 2023-12-31 to 2024-12-31. CLMT currently screens at market cap $2.89B.
MS does not have a complete income-statement cache yet.
CLMT currently screens at market cap $2.89B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the CLMT and MS stock pages for the full models.
Not investment advice.